News

July 1, 2021 - As people get out more in the sun over the summer, it’s appropriate that July is UV Safety Month. Consider how you are protecting yourself from long-lasting damage, such as a variety of forms of skin…   Read More

June 29, 2021 - The most common cancers are breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, melanoma of the skin, bladder cancer, non-Hodgkin’s lymphoma, kidney and renal pelvis cancer, endometrial cancer, leukemia, pancreatic cancer, thyroid…   Read More

June 25, 2021 - Imaging Endpoints is continuing its trajectory of growth – likely the fastest growing imaging CRO (iCRO). We are looking for talented, motivated and best-in-class individuals to join our amazing team around the globe. From operations to…   Read More

June 24, 2021 - Immunotherapy is the most promising cancer treatment for many patients. As the world’s largest oncology focused imaging CRO, Imaging Endpoints utilizes novel response criteria, including pseudoprogression analysis, to optimize data on patient response in all phases…   Read More

June 17, 2021 - Imaging Endpoints is proud to have participated in the latest Society of Nuclear Medicine and Molecular Imaging Annual Meeting to share some of the many new technologies and methodologies deployed at Imaging Endpoints to advance clinical…   Read More

June 10, 2021 - During June, Cancer Survivor Month, take a moment to recognize one of the nearly 17 million Americans battling or who have battled this often-deadly disease. Join us as we celebrate acquittances, friends and loved ones through…   Read More

June 4, 2021 - Imaging Endpoints is excited to participate as a sponsor once again for the ASCO Annual Meeting. This year, we will have a virtual presence as an exhibitor. To meet with us, drop your card at our…   Read More

June 3, 2021 - The imaging field has many exciting developments in the pipeline for oncology. When looking to the future, Imaging Endpoints’ Chief Medical Officer Ron Korn, M.D., Ph.D., has been a strong proponent of the potential of Positron…   Read More

May 20, 2021 - Bladder cancer patients tend to have a survival rate of almost 80%. Through work with researchers on clinical trials, our advanced imaging techniques are helping find new therapies that positively impact patients and their families daily.…   Read More

May 18, 2021 - Imaging Endpoints is known for superior science and the exceptional quality of our work in clinical trials. This is evidenced through our exceptional client retention rate over the last decade – in addition to adding new…   Read More